⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OLMA News
Olema Pharmaceuticals, Inc. Common Stock
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OLMA
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
globenewswire.com
LLY
NTHI
OLMA
PFE
Form 8-K
sec.gov
OLMA
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
globenewswire.com
OLMA
Form 8-K
sec.gov
OLMA
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
globenewswire.com
OLMA
Olema Oncology to Participate in Upcoming Investor Conferences
globenewswire.com
OLMA
Form 8-K
sec.gov
OLMA
Olema Oncology Reports First Quarter 2026 Financial and Operating Results
globenewswire.com
OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OLMA